Ontario Industry Updates, OBIO News Doriane Rey 12/6/23 Ontario Industry Updates, OBIO News Doriane Rey 12/6/23 AmacaThera Closes Series A Extension to Advance Clinical Development of Long Acting, Localized, Non-Opioid Therapeutics to Improve Post-Surgery Patient Care Read More Ontario Industry Updates, OBIO News Doriane Rey 12/6/23 Ontario Industry Updates, OBIO News Doriane Rey 12/6/23 Phenomic AI Enters Strategic Collaborations with Boehringer Ingelheim & Astellas Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 QurCan to participate in Novo Nordisk's program Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 Vasomune Therapeutics and AnGes drug candidate AV-001 receives positive recommendation from the IDSMB for AV001-004 phase 2a study Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 KA Imaging to showcase growing family of Reveal products at RSNA Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 Ontario biotech start-ups get government funding boost Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 Northern Nanopore Instruments acquired by Oxford Nanopore Technologies Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 Enhanced Medical Nutrition over-subscribes pre-series A financing, announces strategic investment from dsm-firmenich Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 Edesa Biotech to receive up to CAD $23 Million in funding from Federal Government Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 Specific Biologics announces additional investment and appointment of experienced biotechnology leader to the Board of Directors Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 Ironstone Product Development (IPD) acquired by global medtech leader, Avania Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 Innovation Factory expands support for high-potential life science innovators by introducing medtech manufacturing funding program Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 Flosonics Medical among HeartX Accelerator’s selected companies for the 2023 program Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 AI at the bedside: First-ever Extubation Decision Support Product approved in Canada Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 FluidAI Medical announces $15M in Series A funding for AI-driven postoperative monitor at HLTH 2023 Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 Conavi Medical announces closing of financing to bolster novel intravascular imaging technology Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 Allarta receives award from JDRF to advance its work in creating a functional cure for type 1 diabetes Read More OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 Zucara Therapeutics doses first patient in Phase 2a ‘ZONE’ trial Read More OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 Paradox Immunotherapeutics is BIO’s emerging Start-Up Stadium winner Read More OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 Ontario Brain Institute announces $600,000 in funding to the NERVE cohort Read More Newer Posts Older Posts
Ontario Industry Updates, OBIO News Doriane Rey 12/6/23 Ontario Industry Updates, OBIO News Doriane Rey 12/6/23 AmacaThera Closes Series A Extension to Advance Clinical Development of Long Acting, Localized, Non-Opioid Therapeutics to Improve Post-Surgery Patient Care Read More
Ontario Industry Updates, OBIO News Doriane Rey 12/6/23 Ontario Industry Updates, OBIO News Doriane Rey 12/6/23 Phenomic AI Enters Strategic Collaborations with Boehringer Ingelheim & Astellas Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 QurCan to participate in Novo Nordisk's program Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 Vasomune Therapeutics and AnGes drug candidate AV-001 receives positive recommendation from the IDSMB for AV001-004 phase 2a study Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/22/23 KA Imaging to showcase growing family of Reveal products at RSNA Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 Ontario biotech start-ups get government funding boost Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 Northern Nanopore Instruments acquired by Oxford Nanopore Technologies Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 Enhanced Medical Nutrition over-subscribes pre-series A financing, announces strategic investment from dsm-firmenich Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 Edesa Biotech to receive up to CAD $23 Million in funding from Federal Government Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 Specific Biologics announces additional investment and appointment of experienced biotechnology leader to the Board of Directors Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 Ironstone Product Development (IPD) acquired by global medtech leader, Avania Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 Innovation Factory expands support for high-potential life science innovators by introducing medtech manufacturing funding program Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 Flosonics Medical among HeartX Accelerator’s selected companies for the 2023 program Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 AI at the bedside: First-ever Extubation Decision Support Product approved in Canada Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 FluidAI Medical announces $15M in Series A funding for AI-driven postoperative monitor at HLTH 2023 Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 Conavi Medical announces closing of financing to bolster novel intravascular imaging technology Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 Allarta receives award from JDRF to advance its work in creating a functional cure for type 1 diabetes Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 Zucara Therapeutics doses first patient in Phase 2a ‘ZONE’ trial Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 Paradox Immunotherapeutics is BIO’s emerging Start-Up Stadium winner Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 Ontario Brain Institute announces $600,000 in funding to the NERVE cohort Read More